Preconception Medications for Women of Childbearing Age
All women of childbearing age (12-45 years) with preserved fertility should take 400-800 μg (0.4-0.8 mg) of folic acid daily in a multivitamin supplement, starting at least 2-3 months before conception and continuing through the first trimester, regardless of whether pregnancy is planned. 1
Core Recommendation: Folic Acid Supplementation
Standard-Risk Women
- Take 400-800 μg (0.4-0.8 mg) folic acid daily beginning at least 1-3 months before conception and continuing through the first trimester 1
- This dose reduces neural tube defects by 50-70%, preventing approximately 2,000-2,800 cases annually in the United States 1
- Folic acid should be taken as part of a multivitamin containing 2.6 μg/day of vitamin B12 to address theoretical concerns about masking B12 deficiency 2
- After 12 weeks gestation, continue 400-1000 μg daily through pregnancy and 4-6 weeks postpartum or throughout breastfeeding 2
High-Risk Women Requiring 4-5 mg Daily
Women in the following categories require 4,000-5,000 μg (4-5 mg) folic acid daily, starting at least 3 months before conception:
- Personal or family history of neural tube defects (first-, second-, or third-degree relative with spina bifida or anencephaly) 1, 3
- Taking antiepileptic medications (valproic acid, carbamazepine, lamotrigine, phenytoin) 1, 3
- Type 1 or type 2 diabetes mellitus 1
- Previous pregnancy affected by neural tube defect 3, 2
- Obesity (BMI >30 kg/m²) 1
For high-risk women, continue 4-5 mg daily through 12 weeks gestation, then reduce to 400-1000 μg daily for the remainder of pregnancy 3, 2
Critical Timing Considerations
- Neural tube closure occurs within 28 days after conception, often before women know they are pregnant 1, 3
- Optimal protection requires starting supplementation at least 3 months before conception for high-risk women and 1-3 months for standard-risk women 1
- Since 50% of pregnancies are unplanned, all women of reproductive age should take folic acid regardless of pregnancy intention 1
Additional Preconception Interventions
Vaccinations
- Rubella vaccination if seronegative—provides protective immunity and prevents congenital rubella syndrome 1
- Hepatitis B vaccination for women at risk—prevents transmission to infants and eliminates maternal risk of hepatic failure, cirrhosis, and death 1
Screening and Optimization
- HIV screening—early identification allows timely antiretroviral treatment to prevent mother-to-child transmission 1
- Thyroid function assessment in women with hypothyroidism—levothyroxine dosage increases during early pregnancy and requires adjustment for proper fetal neurologic development 1
- Diabetes optimization—achieving proper glycemic control before conception reduces the three-fold increase in birth defects from 15% to baseline levels 1
Lifestyle Modifications
- Complete alcohol cessation—no amount is safe at any time during pregnancy, and harm occurs before pregnancy recognition 1
- Smoking cessation before conception—only 20% of women successfully quit during pregnancy, making preconception cessation essential 1
- Weight loss in obese women—reduces risks of neural tube defects, preterm delivery, gestational diabetes, cesarean section, and thromboembolic disease 1
Medication Review and Adjustments
Teratogenic Medications to Discontinue or Modify
- Isotretinoin (Accutane®)—causes miscarriage and birth defects; requires effective pregnancy prevention 1
- Warfarin—switch to non-teratogenic anticoagulant before conception 1
- High-dose antiepileptic drugs—reduce to lowest effective dose, particularly valproic acid 1
Special Considerations for Phenylketonuria
- Women with PKU must adhere to a low phenylalanine diet before conception and throughout pregnancy to prevent fetal mental retardation 1
Important Safety Considerations
Vitamin B12 Deficiency Concerns
- Folic acid doses above 1 mg daily theoretically could mask vitamin B12 deficiency (pernicious anemia) while allowing neurologic damage to progress 4
- However, routine B12 screening before initiating folic acid is not required for women planning pregnancy 2
- Taking folic acid in a multivitamin containing 2.6 μg/day of vitamin B12 mitigates this theoretical concern 2
Drug Interactions
- Phenytoin's anticonvulsant action may be antagonized by folic acid—patients with well-controlled epilepsy may require dose adjustments 4
- Methotrexate, barbiturates, and alcohol consumption interfere with folate metabolism 4
Practical Implementation Algorithm
For ALL women of childbearing age at routine visits (contraception renewal, Pap testing, annual exams):
Assess pregnancy risk category:
- Standard risk → 400-800 μg folic acid daily
- High risk (diabetes, epilepsy, obesity, family history of NTD, prior NTD pregnancy) → 4-5 mg folic acid daily
Prescribe appropriate multivitamin:
- Standard risk: Over-the-counter prenatal multivitamin with 400-800 μg folic acid
- High risk: Prescription 5 mg folic acid tablet PLUS standard multivitamin (do not exceed one multivitamin daily) 2
Counsel on timing:
- Start immediately if sexually active without reliable contraception
- Start 3 months before planned conception for high-risk women
- Start 1-3 months before planned conception for standard-risk women
Review and optimize:
- Update vaccinations (rubella, hepatitis B if indicated)
- Screen for HIV, optimize diabetes/thyroid control
- Discontinue teratogenic medications
- Counsel on complete alcohol and tobacco cessation
Common Pitfalls to Avoid
- Waiting until pregnancy confirmation to start folic acid—neural tube closure occurs by day 28, often before the first prenatal visit 1, 3
- Assuming dietary folate alone is sufficient—supplementation is required to achieve red blood cell folate levels associated with maximal NTD protection 2
- Prescribing multiple multivitamin tablets to achieve high-dose folic acid—women needing >1 mg should take ONE multivitamin plus additional folic acid-only tablets 2
- Forgetting to counsel women not planning pregnancy—50% of pregnancies are unplanned, making universal supplementation essential 1